Evidence map›Paper›PMID 31277455›Full record

ArticlePharmaceutics2019

Development of Bioinspired Gelatin and Gelatin/Chitosan Bilayer Hydrofilms for Wound Healing.

Itxaso Garcia-Orue, Edorta Santos-Vizcaino, Alaitz Etxabide, Jone Uranga, Ardeshir Bayat, Pedro Guerrero, Manoli Igartua, Koro de la Caba, Rosa Maria Hernandez

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 69 citations in OpenAlex.

  1. ACS omega · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Itxaso Garcia-OrueNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-2143-5260
Edorta Santos-VizcainoNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-7064-4563
Alaitz EtxabideBIOMAT Research Group, Chemical and Environmental Engineering Department, Engineering College of Gipuzkoa, University of the Basque Country (UPV/EHU), Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain.ORCID 0000-0002-8025-0717
Jone UrangaBIOMAT Research Group, Chemical and Environmental Engineering Department, Engineering College of Gipuzkoa, University of the Basque Country (UPV/EHU), Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain.
Ardeshir BayatPlastic & Reconstructive Surgery Research, Division of Musculoskeletal & Dermatological Sciences, School of Biological Sciences, University of Manchester, M13 9PL Manchester, UK. rosa.hernandez@ehu.es.ORCID 0000-0002-4116-6491
Pedro GuerreroBIOMAT Research Group, Chemical and Environmental Engineering Department, Engineering College of Gipuzkoa, University of the Basque Country (UPV/EHU), Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain.ORCID 0000-0002-9785-7048
Manoli IgartuaNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0003-0283-7923
Koro de la CabaBIOMAT Research Group, Chemical and Environmental Engineering Department, Engineering College of Gipuzkoa, University of the Basque Country (UPV/EHU), Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain.
Rosa Maria HernandezNanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain. ardeshir.bayat@manchester.ac.uk.ORCID 0000-0002-3947-409X
University of the Basque Country · ESUniversity of Manchester · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

In the current study, we developed a novel gelatin-based bilayer wound dressing. We used different crosslinking agents to confer unique properties to each layer, obtaining a bioinspired multifunctional hydrofilm suitable for wound healing. First, we produced a resistant and non-degradable upper layer by lactose-mediated crosslinking of gelatin, which provided mechanical support and protection to overall design. For the lower layer, we crosslinked gelatin with citric acid, resulting in a porous matrix with a great swelling ability. In addition, we incorporated chitosan into the lower layer to harness its wound healing ability. FTIR and SEM analyses showed that lactose addition changed the secondary structure of gelatin, leading to a more compact and smoother structure than that obtained with citric acid. The hydrofilm was able to swell 384.2 ± 57.2% of its dry weight while maintaining mechanical integrity. Besides, its water vapour transmission rate was in the range of commercial dressings (1381.5 ± 108.6 g/m

Indexed as

bilayer dressingchitosanex vivo modelgelatinhuman skinwound healing

Identifiers

PMID31277455
PMCPMC6680716
OpenAlexW2954407453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.